HIV Research: Paving the Way to COVID Vaccines

The rapid development of COVID vaccines would not have been possible without innovative foundations developed through HIV vaccine research.

• Participants Sought for HIV-COVID-19 Study
• Mimicking CD4: A Bait and Switch Approach to Immunotherapy
• CAR Cells, Revved Up

U.S. Sees Progress on HIV, Room for Improvement

CDC reports show “hopeful signs of progress,” including 8% decline in new HIV infections from 2015 to 2019.

• amfAR’s Greg Millett Presents on 40th Anniversary of HIV/AIDS
• FDA Approves Long-Acting Injectable to Treat HIV

Getting PrEP to Key Populations Is Critical to Global Fight Against HIV

amfAR's Greg Millett and TREAT Asia's Dr. Annette Sohn participated in the 2021 Conference on Retroviruses and Opportunistic Infections (CROI), held virtually March 6-10.

• ViiV Healthcare and TREAT Asia Partner on Important New Study of Young Adults with HIV
• amfAR’s Greg Millett Presents at Smithsonian World AIDS Day Event

amfAR’s Epic Voices Series Wins Award

PRNEWS panel declared amfAR’s Epic Voices to be inspiring, innovative, and deserving of industry-wide recognition for its impact on the global community.

Connections - Episode 6: COVID & HIV – Jonathan Cohen

Meet Jonathan Cohen, Director of the Global Public Health Program at Open Society Foundations. Jonathan spoke to amfAR about an opinion piece he wrote for STAT News, where he discussed his decision to publicly disclose his HIV status upon getting a Covid-19 vaccination.

COVID-19 and HIV/AIDS

We are constantly gathering new information to keep you up to date on the intersection between HIV and COVID-19. The hard-won lessons of HIV research are informing the race to find effective treatments and a vaccine for COVID-19.